Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety monitoring of dihydroartemisinin-piperaquine, artemether-lumefantrine, and artesunate-amodiaquine for uncomplicated falciparum malaria
PACTR201305000552290Completed
- Sponsor
- Cheikh Anta Diop University
- Start
- Oct 2011
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of artemether, lumefantrine, artesunate, amodiaquine, dihydroartemisinin and 1 more in Malaria (3 arms), sponsored by Cheikh Anta Diop University. Primary endpoint: PCR-corrected adequate clinical and parasitological response at day 28. Started Oct 2011; status: completed.
02
Drugs
artemetherlumefantrineartesunateamodiaquinedihydroartemisinin
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR201305000552290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201305000552290.